In response to the rising incidence of indolent, low-risk prostate cancer (PCa) due to
increased prostate-specific antigen (PSA) screening in the 1990s, active surveillance (AS) …

Objective To systematically review the evidence for interventions addressing key domains of
the American Cancer Society (ACS) and American Society of Clinical Oncology (ASCO) …

Importance Active surveillance (AS) is endorsed by clinical guidelines as the preferred
management strategy for low-risk prostate cancer, but its use in contemporary clinical …

PURPOSE The 17-gene Onco type DX Genomic Prostate Score (GPS) test predicts adverse
pathology (AP) in patients with low-risk prostate cancer treated with immediate surgery. We …

Importance Active surveillance is increasingly recognized as the preferred standard of care
for men with low-risk prostate cancer. However, active surveillance requires repeated …

Introduction Recent technological advancements and the introduction of modern anatomical
and functional sequences have led to a growing role for multiparametric magnetic …

Introduction Active surveillance (AS) has been widely adopted for the management of men
with low-risk prostate cancer. However, there is still a lack of consensus surrounding the …

Background Active surveillance (AS)/watchful waiting (WW) strategy for localized prostate
cancer (PCa) is increasingly and broadly endorsed as a preferred option for initial treatment …

The primary goal of active surveillance (AS) is to prevent overtreatment by selecting patients
with low-risk prostate cancer (PCa) and closely monitoring them so that definitive treatment …

Importance Outcomes from protocol-directed active surveillance for favorable-risk prostate
cancers are needed to support decision-making. Objective To characterize the long-term …